Innate immune-mediated neuronal injury consequent to loss of astrocytes

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 6, 2008, Pages 590-599

  Darlington, Peter J ^a   Podjaski, Cornelia ^a   Horn, Katherine E ^a   Costantino, Santiago ^a,b   Blain, Manon ^a   Saikali, Philippe ^a   Chen, Zhihong ^c   Baker, Kenneth Adam ^a   Newcombe, Jia ^d   Freedman, Mark ^c   Wiseman, Paul W ^b   Bar Or, Amit ^a   Kennedy, Timothy E ^a,b   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Astrocyte; Caspase; GFAP; Innate immune system; Neuroinflammation; Neuronal death; Vimentin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR NKG2D; VIMENTIN;

ADULT; AGED; ARTICLE; ASTROCYTE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NERVE CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WHITE MATTER;

ASTROCYTES; BLOTTING, WESTERN; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; MULTIPLE SCLEROSIS; NEURONS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; VIMENTIN;

EID: 44649163942     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181772cf6     Document Type: Article

References (43)

1. Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002;125:1751-59
2. Bien CG, Bauer J. T-cells in human encephalitis. Neuromolecular Med 2005;7:243-53
3. Aktas O, Ullrich O, Infante-Duarte C, et al. Neuronal damage in brain inflammation. Arch Neurol 2007;64:185-89
4. Hoftberger R, Aboul-Enein F, Brück W, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol 2004;14:43-50
5. Medana I, Martinic MA, Wekerle H, et al. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 2001;159:809-15
6. Linker RA, Sendtner M, Gold R. Mechanisms of axonal degeneration in EAE - Lessons from CNTF and MHC I knockout mice. J Neurol Sci 2005;233:167-72
7. Linker RA, Rott E, Hofstetter HH, et al. EAE in beta-2 microglobulin-deficient mice: Axonal damage is not dependent on MHC-I restricted immune responses. Neurobiol Dis 2005;19:218-28
8. Nitsch R, Pohl EE, Smorodchenko A, et al. Direct impact of T cells on neurons revealed by two-photon microscopy in living brain tissue. J Neurosci 2004;24:2458-64
9. Giuliani F, Goodyer CG, Antel JP, et al. Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 2003;171:368-79
10. Maragakis NJ, Rothstein JD. Mechanisms of disease: Astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006;2:679-89
11. Bauer J, Elger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007;62:67-80
12. Bien CG, Bauer J, Deckwerth TL, et al. Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002;51:311-18
13. Itoyama Y, Webster HD, Richardson EP Jr, et al. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol 1983;14:339-46
14. Itoyama Y, Ohnishi A, Tateishi J, et al. Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP). Acta Neuropathol 1985;65:217-23
15. Blakemore WF. Transplanted cultured type-1 astrocytes can be used to reconstitute the glia limitans of the CNS: The structure which prevents Schwann cells from myelinating CNS axons. Neuropathol Appl Neurobiol 1992;18:460-66
16. Newcombe J, Uddin A, Dove R, et al. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 2008;18:52-61
17. McPherson SW, Heuss ND, Roehrich H, et al. Bystander killing of neurons by cytotoxic T cells specific for a glial antigen. Glia 2006;53:457-66
18. Ousman SS, Tomooka BH, van Noort JM, et al. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 2007;448:474-79
19. Traugott U, Raine CS. Further lymphocyte characterization in the central nervous system in multiple sclerosis. Ann N Y Acad Sci 1984;436:163-80
20. Wucherpfennig KW, Newcombe J, Li H, et al. Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proc Natl Acad Sci U S A 1992;89:4588-92
21. Huang D, Shi FD, Jung S, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 2006;20:896-905
22. Saikali P, Antel JP, Newcombe J, et al. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J Neurosci 2007;27:1220-28
23. Antel JP, McCrea E, Ladiwala U, et al. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: Relation with CD56 expression. J Immunol 1998;160:1606-11
24. Hickey WF, Ueno K, Hiserodt JC, et al. Exogenously-induced, natural killer cell-mediated neuronal killing: A novel pathogenetic mechanism. J Exp Med 1992;176:811-17
25. Backstrom E, Chambers BJ, Ho EL, et al. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol 2003;33:92-100
26. Backstrom E, Chambers BJ, Kristensson K, et al. Direct NK cell-mediated lysis of syngenic dorsal root ganglia neurons in vitro. J Immunol 2000;165:4895-900
27. Barber DF, Faure M, Long EO. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 2004;173:3653-59
28. Darlington PJ, Goldman JS, Cui QL, et al. Widespread immunoreactivity for neuronal nuclei in cultured human and rodent astrocytes. J Neurochem 2008;104:1201-209
29. Zeine R, Pon R, Ladiwala U, et al. Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: Relevance to multiple sclerosis. J Neuroimmunol 1998;87:49-61
30. Crocker JC, Grier DG. Methods of digital video microscopy for colloidal studies. J Colloid Interface Sci 1996;298:179
31. Wang T, Allie R, Conant K, et al. Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J 2006;20:1209-11
32. Zhang Y, Goodyer C, LeBlanc A. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J Neurosci 2000;20:8384-89
33. Mouser PE, Head E, Ha KH, et al. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am J Pathol 2006;168:936-46
34. Newcombe J, Woodroofe MN, Cuzner ML. Distribution of glial fibrillary acidic protein in gliosed human white matter. J Neurochem 1986;47:1713-19
35. Verkhratsky A, Toescu EC. Neuronal-glial networks as substrate for CNS integration. J Cell Mol Med 2006;10:826-36
36. Morse RH, Seguin R, McCrea EL, et al. NK cell-mediated lysis of autologous human oligodendrocytes. J Immunol 2001;116:107-15
37. Provinciali M, Di SG, Fabris N. Optimization of cytotoxic assay by target cell retention of the fluorescent dye carboxyfluorescein diacetate (CFDA) and comparison with conventional 51CR release assay. J Immunol Methods 1992;155:19-24
38. Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000;408:57-63
39. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-35
40. Takahashi K, Aranami T, Endoh M, et al. The regulatory role of natural killer cells in multiple sclerosis. Brain 2004;127:1917-27
41. Muller M, Carter SL, Hofer MJ, et al. Signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory t cells in the central nervous system. J Immunol 2007;179:2774-86
42. Otani N, Nawashiro H, Fukui S, et al. Enhanced hippocampal neurodegeneration after traumatic or kainate excitotoxicity in GFAP-null mice. J Clin Neurosci 2006;13:934-38
43. Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004;21:357-66